# Neuphoria Therapeutics Inc.: Form 8-K, filed Oct 27, 2025

- Company: [Neuphoria Therapeutics Inc.](/companies/neup.md) (CIK 1191070)
- Form: 8-K
- Filed: 2025-10-27
- Accepted by EDGAR: Oct 27, 2025, 20:19 ET
- Period: 2025-10-27
- Accession: 0001213900-25-102607
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1191070/000121390025102607/ea0262561-8k_neuphoria.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1191070/000121390025102607/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 3.03: Change to security holders’ rights
- Item 5.03: Amendment to articles or bylaws
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1191070/000121390025102607/ea0262561-8k_neuphoria.htm

Filed Oct 27, 2025.
Source: SEC EDGAR, the filing index for accession 0001213900-25-102607. Last ingested by Listed: Oct 24, 2026, 15:10 ET. No prices; not investment advice.